β-lapachone induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2 family and activation of caspases

Experimental Oncology

Volumn 28, Issue 1, 2006, Pages 30-35

  Lee, J I ^a   Choi, D Y ^a   Chung, H S ^a   Seo, H G ^a   Woo, H J ^b   Choi, B T ^b   Choi, Y H ^b  

^a Korea Science Academy   (South Korea)

^b Dong Eui University   (South Korea)

Author keywords

lapachone; Apoptosis; Bcl 2 family; Caspases; T24 bladder cancer cells

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ACTIN; APOPTOSIS INHIBITOR; BETA CATENIN; BETA LAPACHONE; CASPASE; CASPASE 3; CASPASE 9; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE C GAMMA1; PROTEIN BAX; PROTEIN BCL 2; QUINONE DERIVATIVE; TRYPAN BLUE;

AGAR GEL ELECTROPHORESIS; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BARK; BLADDER CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TABEBUIA; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; CASPASES; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; NAPHTHOQUINONES; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE INHIBITORS; RNA, MESSENGER; TUMOR NECROSIS FACTORS; URINARY BLADDER NEOPLASMS;

EID: 33646066835     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bae SS, Perry DK, Oh YS, Choi JH, Galadari SH, Ghayur T, Ryu SH, Hannun YA, Suh PG. Proteolytic cleavage of phospholipase C-γ1 during apoptosis in Molt-4 cells. FASEB J 2000; 14: 1083-92.
2. Boothman DA, Trask DK, Pardee AB. Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I. Cancer Res 1989; 49: 605-12.
3. Chorna I, Fedorenko O, Datsyuk L, Stoika R. Expression of mRNA coding for TGF-β and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin. Exp Oncol 2005; 27: 156-8.
4. D'Agostini F, Izzotti A, Balansky RM, Bennicelli C, De Flora S. Modulation of apoptosis by cancer chemopreventive agents. Mutat Res 2005; 591: 173-86.
5. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004; 53: 153-9.
6. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999; 13: 239-52.
7. Fernandez VS, Stoppani AO, Dubin M. Redox cycling of β-lapachone and structural analogues in microsomal and cytosol liver preparations. Methods Enzymol 2004; 378: 67-87.
8. Frydman B, Marton LJ, Sun JS, Neder K, Witiak DT, Liu AA, Wang HM, Mao Y, Wu HY, Sanders MM, Liu LF. Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones. Cancer Res 1997; 57: 620-27.
9. Fukuda K. Apoptosis-associated cleavage of β-catenin in human colon cancer and rat hepatoma cells. Int J Biochem Cell Biol 1999; 31: 519-29.
10. Goijman SG, Stoppani AO. Effects of β-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi. Arch Biochem Biophys 1985; 240: 273-80.
11. Guiraud P, Steiman R, Campos-Takaki GM, Seigle-Murandi F, Simeon de Buochberg M. Comparison of antibacterial and antifungal activities of lapachol and β-lapachone. Planta Med 1994; 60: 373-4.
12. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
13. Jiang C, Yang YF, Cheng SH. Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther 2004; 4: 33-9.
14. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose polymerase by a proteinase with properties like ICE. Nature 1994; 371: 346-7.
15. Li CJ, Averboukh L, Pardee AB. β-lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem 1993; 268: 22463-8.
16. Li CJ, Wang C, Pardee AB. Induction of apoptosis by β-lapachone in human prostate cancer cells. Cancer Res 1995; 55: 3712-5.
17. Lopes JN, Cruz FS, Docampo R, Vasconcellos ME, Sampaio MC, Pinto AV, Gilbert B. In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi. Ann Trop Med Parasitol 1978; 72: 523-31.
18. O'Brien DI, Nally K, Kelly RG, O'Connor TM, Shanahan F, O'Connell J. Targeting the Fas/Fas ligand pathway in cancer. Expert Opin Ther Targets 2005; 9: 1031-44.
19. Pardee AB, Li YZ, Li CJ. Cancer therapy with β-lapachone. Curr Cancer Drug Targets 2002; 2: 227-42.
20. Philchenkov A, Zavelevich M, Kroczak TJ, Los M. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol 2004; 26: 82-97.
21. Schaffner-Sabba K, Schmidt-Ruppin KH, Wehrli W, Schuerch AR, Wasley JW. β-lapachone: synthesis of derivatives and activities in tumor models. J Med Chem 1984; 27: 990-4.
22. Walker PR, Sikorska M. New aspects of the mechanism of DNA fragmentation in apoptosis. Biochem Cell Biol 1997; 75: 287-99.